Dasatinib Sandoz 50 mg, Filmtabletten - 60 Swissmedic Key 67368002 Registration Holder Sandoz Pharmaceuticals AG Name Dasatinib Sandoz 50 mg, Filmtabletten Date of registration 08.10.2020 Original/Generic Generic Introduction of Sequence 08.10.2020 ATC-Classification Dasatinib (L01EA02) Revision date WHO WHO-DDD Valid until 07.10.2025 Index Therapeuticus (BSV) 07.16.10. Show package size 60 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 1072.75 Limitation Yes Limitation text
Deductible 10 % Consumer price 1239.25 Feedback FB Daily cost GTIN 7680673680025 Medication Code Synthetika Pharmacode Disponibility
Composition dasatinibum 50 mg, cellulosum microcristallinum, lactosum monohydricum 69 mg, carmellosum natricum conexum, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, glyceroli monopalmitostearas, natrii laurilsulfas, pro compresso obducto corresp. natrium 1.456 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dasatinib 50 mg
BAG: Active Agent Dose Dasatinib 50 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Glyceroli Monopalmitostearas Hydroxypropylcellulosum Lactose Monohydrate 69 mg Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 06.01.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
